News
Vital update for Valneva’s COVID-19 vaccine
Valneva has announced further data emerging from a study of its inactivated COVID-19 vaccine, VLA2001. Meanwhile, the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion for the use of VLA2001 in adults of 18 to 50 years of age.